|
Market Closed -
NYSE
16:00:00 2026-11-11 EST
|
Pre-market 07:42:00 | |||
| 1.110 USD | +6.73% |
|
1.085 | -2.25% |
| 10-29 | Lineage Cell Therapeutics Provides Update On ReSonance Program For Hearing Loss | CI |
| 09-30 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| LCTX | Delayed | |
CBOE
| LCTX | Real-time | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | Delayed | |
|
Deutsche Boerse AG
| BT3 | Delayed | |
|
Börse Stuttgart
| BT3 | Delayed | |
|
Tradegate
| BT3 | Real-time | |
|
Boerse Muenchen
| BT3 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 1.14 | 1.35 | 1.35 |
| Spread/Res. | -2.63% | -17.78% | -17.78% |
| Spread/Supp. | +11.00% | +22.76% | +19.32% |
| Support | 1 | 0.9042 | 0.9303 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
